93 Results (Page 3 of 4)
South Korea Markets Research Reports
South Korea Vaccines Market Analysis
This report presents a strategic analysis of the South Korean vaccine market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Korean vaccine market, offering unmatched value, accuracy, and expert insights.
South Korea Physiotherapy Market Analysis
South Korea's physiotherapy market size was valued at $0.77 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.85% from 2022 to 2030 and will reach $1.32 Bn in 2030. The South Korean physiotherapy market is expected to grow due to the increasing prevalence of chronic diseases and lack of awareness of physiotherapy. The market is segmented by Product Type, Application Type, and End User. The major players in the South Korean physiotherapy market are Medi-Ject Co., Ltd, Sun Medical Equipment Co., Ltd, Hanyang Medical, BTL Industries, and others.
South Korea Oncology Therapeutics Market Analysis
By 2030, the South Korea Oncology Therapeutics Market is anticipated to reach a value of $5.4 Bn from $2.7 Bn in 2022, growing at a CAGR of 9.4% during 2022-30. The Oncology Therapeutics Market in South Korea is dominated by a few domestic pharmaceutical companies such as Celltrion, Green Cross, and Kolon Life Science. The Oncology Therapeutics Market in South Korea is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for South Korea Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
South Korea Telemedicine Market Analysis
This report presents a strategic analysis of the South Korea Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Telemedicine Market, offering unmatched value, accuracy and expert insights.
South Korea Diabetes Therapeutics Market Analysis
South Korean diabetes therapeutics market is expected to witness growth from $2.1 Bn in 2022 to $4.7 Bn in 2030 with a CAGR of 10.7% for the forecasted year 2022-30. The increase in the prevalence of diabetes in South Korea, as well as government policies designed to promote awareness of diabetes in South Korea, are the major market drivers. The South Korean diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Chong Kun Dang, Kwang Dong Pharmaceutical, and Boehringer Ingelheim are the major players in the South Korean diabetes therapeutics market.
South Korea Clinical Trials Support Service Market Analysis
This report presents a strategic analysis of the South Korea Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.
South Korea Cancer Immunotherapy Market Analysis
South Korean cancer immunotherapy market is expected to grow from $1.64 Bn in 2022 to $3.06 Bn in 2030 with a CAGR of 8.1% for the forecasted year 2022-30. The increase in the ageing population and the demand for new and innovative treatment options in South Korea have led to the growth of the market. The South Korean cancer immunotherapy market is segmented by type, application, and end user. Selecxine, Panolos Bioscience, and Bayer are the major players in the South Korean cancer immunotherapy market.
South Korea Diabetes Devices Market Analysis
South Korea's diabetes devices market is expected to witness growth from $332 Mn in 2022 to $624 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. The South Korean elderly population is predicted to raise the number of diabetes diagnoses, which will increase demand for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Dongmun, Sejung Medical Industry, Medyssey, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
South Korea Electronic Health Records Market Analysis
South Korea's Electronic Health Record (EHR) market size was valued at $413 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5% from 2022 to 2030 and will reach $611 Mn in 2030. South Korean EHR market growth can be attributed to the growing need for better patient care and safety. The market is segmented by product, application, and end user. The key market players are Allscripts, Cerner, Epic Systems, and others.
South Korea Oncology Drugs Market Analysis
South Korea's oncology drugs market size is at around $2.89 Bn in 2022 and is projected to reach $7.41 Bn in 2030, exhibiting a CAGR of 12.6% during the forecast period 2022-2030. The oncology industry is being segmented into drug class, therapy, indication, and dosage. The driving factors for the oncology drug market are increasing awareness among people, cutting-edge technology, and increasing clinical trials. Company examples: Bristol-Myers Squibb, Roche, Merck & Co, Novartis, Johnson & Johnson
South Korea Digital Health Market Analysis
This report presents a strategic analysis of the South Korea Digital Health Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Digital Health Market, offering unmatched value, accuracy and expert insights.
South Korea 3D Imaging Market Analysis
South Korea's 3D imaging market is projected to grow from $0.44 Bn in 2022 to $1.61 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. The market will be driven by the implementation of new 3D imaging technology, applications, and support from the government sector. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Samsung Medison.
South Korea Cardiovascular Diseases Therapeutics Market Analysis
The South Korean cardiovascular disease therapeutics market is projected to grow from $2.37 Bn in 2022 to $4.47 Bn in 2030 with a CAGR of 8.22% for the year 2022-2030. The increasing awareness of cardiovascular diseases and the rising ageing population are responsible for the growth of the market. The South Korean cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Kolmar, Kwang Dong Pharmaceutical, and AstraZeneca are the major players in the South Korean cardiovascular disease therapeutics market.
South Korea Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea Lung Cancer Therapeutics Market will reach a value of $875 Mn from $435 Mn in 2022, growing at a CAGR of 9.1% during 2022-2030. The Lung Cancer Therapeutics Market in South Korea is dominated by a few domestic pharmaceutical companies such as Yuhan Corporation, Hanmi Pharmaceutical, and Celltrion Healthcare. The Lung Cancer Therapeutics Market in South Korea is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Korean lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
South Korea Healthcare Insurance Market Analysis
The South Korean healthcare insurance market is projected to grow from $29.61 Bn in 2022 to $57.28 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be rising healthcare costs, increasing disposable income, government support and technological advancements. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Samsung Life Insurance, Hanwha Life Insurance, Kyobo Life Insurance, KB Insurance and Cigna.
South Korea Anti Aging Therapeutics Market Analysis
South Korea anti-aging therapeutics market is projected to grow from $9 Mn in 2022 to $32 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. Presence of advanced technologies and increases research and development initiatives in South Korea is responsible for the expansion of the market. The South Korea anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading companies in the market include Hanmi Pharmaceuticals, SK Bioscience, and Merz Pharma.
South Korea Oncology Clinical Trials Market Analysis
South Korea's oncology clinical trials market is projected to grow from $184.8 Mn in 2022 to $305.9 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the country's well-established infrastructure, advanced medical facilities, and streamlined regulatory processes. The market is segmented by phase, study design, and indication. Some of the major players include Pfizer Inc., Roche Holding AG & SK Biopharmaceuticals.
South Korea Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea Liver Cancer Therapeutics market will reach a value of $ 167.6 Mn from $42.81 Mn in 2022, growing at a CAGR of 18.6% during 2022-2030. Liver Cancer Therapeutics in South Korea is dominated by a few domestic pharmaceutical companies such as Green Cross Cell Corporation, Handok Pharmaceuticals and Yuhan Corporation. The Liver Cancer Therapeutics market in South Korea is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Korea Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
South Korea Connected Healthcare Market Analysis
The South Korean connected healthcare market is projected to grow from $969.62 Mn in 2022 to $7622.15 Mn by 2030, registering a CAGR of 29.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing geriatric population, high-tech culture, government support and the COVID-19 pandemic. The market is segmented by type, function and by application. Some of the major players include Samsung, SK Telecom, Hanwha Group, Oracle, Philips Healthcare and GE Healthcare.
South Korea Neurology Clinical Trials Market Analysis
The South Korea Neurology Clinical Trials market is projected to grow from $76.4 Mn in 2022 to $126.5 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the supportive regulatory environment and increasing interest from pharmaceutical companies investing in neurology clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Hoffmann-La Roche, Biogen & Chong Kun Dang Pharmaceutical.
South Korea Neurology Devices Market Analysis
South Korea Neurology Device Market size is at around $184.41 Mn in 2022 and is projected to reach $362.07 Mn in 2030, exhibiting a CAGR of 8.8% during the forecast period. With the current rates of prevalence of neurological diseases like stroke, Parkinson’s disease, Multiple Sclerosis, and Epilepsy the demand for neurology devices has also surged. Currently, international players like Boston Scientific, Medtronic, and Stryker dominate the market. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
South Korea HIV Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea HIV therapeutics market will reach a value of $268.9 Mn from $201.1 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030. The market is primarily dominated by local players such as Dong-A ST, Hanmi Pharmaceuticals, and Celltrion. The market for HIV/AIDS treatment in South Korea is primarily driven by government funding and initiatives, social issues like stigma and discrimination, and diagnostic tools. The HIV therapeutics market in South Korea is segmented by type, product, geography, end user, and distribution channel.
South Korea Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis
This report presents a strategic analysis of the South Korea Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.
South Korea Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of the South Korea Blockchain Technology in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Blockchain Technology in Healthcare Market, offering unmatched value, accuracy and expert insights.
South Korea eHealth Market Analysis
This report presents a strategic analysis of the South Korea eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea eHealth Market, offering unmatched value, accuracy and expert insights.
